Company intelligence / Profile preview

LCC Therapeutics Ltd

Runcorn, Cheshire, UKliverpoolchirochem.com ↗

Ownership: Private
Development stage: Preclinical

Overview

LCC Therapeutics has transitioned from a contract research organization to a hub-and-spoke biotech model focused on generating small molecule lead candidates for oncology and rare disease indications. Their chemistry platform has been validated by major pharma and biotech clients. The company recently formed its first strategic partnership with Veritas in Silico for mRNA-targeted therapeutics. No clinical results have been published as of May 2025.

Therapeutic areas: OncologyRare Diseases
Modalities: Small molecules
Industry: Biotech

Partnerships

Veritas in Silico – shared risk projects to discover/develop small molecule therapeutics against multiple mRNA targets

Beyond the preview

Go deeper on LCC Therapeutics Ltd.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on LCC Therapeutics Ltd.

Explore the full profile